Bristol-Myers Squibb Company
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR

Abstract:

The present invention relates to single domain proteins that bind to epidermal growth factor receptor (EGFR). The invention also relates to single domain proteins for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.